{"id":"https://openalex.org/W2002487680","doi":"https://doi.org/10.1016/j.bmcl.2013.08.010","title":"Imidazopyridazines as potent inhibitors of Plasmodium falciparum calcium-dependent protein kinase 1 (PfCDPK1): Preparation and evaluation of pyrazole linked analogues","display_name":"Imidazopyridazines as potent inhibitors of Plasmodium falciparum calcium-dependent protein kinase 1 (PfCDPK1): Preparation and evaluation of pyrazole linked analogues","publication_year":2013,"publication_date":"2013-08-10","ids":{"openalex":"https://openalex.org/W2002487680","doi":"https://doi.org/10.1016/j.bmcl.2013.08.010","mag":"2002487680","pmid":"https://pubmed.ncbi.nlm.nih.gov/24035097","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3809513"},"language":"en","primary_location":{"id":"doi:10.1016/j.bmcl.2013.08.010","doi":"https://doi.org/10.1016/j.bmcl.2013.08.010","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.bmcl.2013.08.010","pdf_url":null,"source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & Medicinal Chemistry Letters","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1016/j.bmcl.2013.08.010","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5001403675","display_name":"Jonathan M. Large","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I109541847","display_name":"LifeArc","ror":"https://ror.org/01dqb0q37","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I109541847"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Jonathan M. Large","raw_affiliation_strings":["Centre for Therapeutics Discovery, MRC Technology, Mill Hill, London NW7 1AD, UK. Electronic address: jonathan.large@tech.mrc.ac.uk","Centre for Therapeutics Discovery, MRC Technology, Mill Hill, London NW7 1AD, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Therapeutics Discovery, MRC Technology, Mill Hill, London NW7 1AD, UK. Electronic address: jonathan.large@tech.mrc.ac.uk","institution_ids":["https://openalex.org/I109541847"]},{"raw_affiliation_string":"Centre for Therapeutics Discovery, MRC Technology, Mill Hill, London NW7 1AD, UK","institution_ids":["https://openalex.org/I109541847"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020419534","display_name":"Simon A. Osborne","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I109541847","display_name":"LifeArc","ror":"https://ror.org/01dqb0q37","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I109541847"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Simon A. Osborne","raw_affiliation_strings":["Centre for Therapeutics Discovery, MRC Technology, Mill Hill, London NW7 1AD, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Therapeutics Discovery, MRC Technology, Mill Hill, London NW7 1AD, UK","institution_ids":["https://openalex.org/I109541847"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065201672","display_name":"Ela Smiljanic-Hurley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I109541847","display_name":"LifeArc","ror":"https://ror.org/01dqb0q37","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I109541847"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Ela Smiljanic-Hurley","raw_affiliation_strings":["Centre for Therapeutics Discovery, MRC Technology, Mill Hill, London NW7 1AD, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Therapeutics Discovery, MRC Technology, Mill Hill, London NW7 1AD, UK","institution_ids":["https://openalex.org/I109541847"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035686174","display_name":"Keith H. Ansell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I109541847","display_name":"LifeArc","ror":"https://ror.org/01dqb0q37","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I109541847"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Keith H. Ansell","raw_affiliation_strings":["Centre for Therapeutics Discovery, MRC Technology, Mill Hill, London NW7 1AD, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Therapeutics Discovery, MRC Technology, Mill Hill, London NW7 1AD, UK","institution_ids":["https://openalex.org/I109541847"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055807167","display_name":"Hayley M. Jones","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I109541847","display_name":"LifeArc","ror":"https://ror.org/01dqb0q37","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I109541847"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Hayley M. Jones","raw_affiliation_strings":["Centre for Therapeutics Discovery, MRC Technology, Mill Hill, London NW7 1AD, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Therapeutics Discovery, MRC Technology, Mill Hill, London NW7 1AD, UK","institution_ids":["https://openalex.org/I109541847"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110847838","display_name":"Debra L. Taylor","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I109541847","display_name":"LifeArc","ror":"https://ror.org/01dqb0q37","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I109541847"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Debra L. Taylor","raw_affiliation_strings":["Centre for Therapeutics Discovery, MRC Technology, Mill Hill, London NW7 1AD, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Therapeutics Discovery, MRC Technology, Mill Hill, London NW7 1AD, UK","institution_ids":["https://openalex.org/I109541847"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069594586","display_name":"Barbara Clough","orcid":"https://orcid.org/0000-0002-3235-6170","observed_orcids":["https://orcid.org/0000-0002-3235-6170"]},"institutions":[{"id":"https://openalex.org/I4405285715","display_name":"National Institute for Medical Research","ror":"https://ror.org/00146rb91","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801081054","https://openalex.org/I4210087105","https://openalex.org/I4405285715","https://openalex.org/I90344618"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Barbara Clough","raw_affiliation_strings":["Division of Parasitology, MRC National Institute for Medical Research, The Ridgeway, Mill, Hill, London NW7 1AA, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Parasitology, MRC National Institute for Medical Research, The Ridgeway, Mill, Hill, London NW7 1AA, UK","institution_ids":["https://openalex.org/I4405285715"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049161625","display_name":"Judith L. Green","orcid":"https://orcid.org/0000-0001-6825-9404","observed_orcids":["https://orcid.org/0000-0001-6825-9404"]},"institutions":[{"id":"https://openalex.org/I4405285715","display_name":"National Institute for Medical Research","ror":"https://ror.org/00146rb91","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801081054","https://openalex.org/I4210087105","https://openalex.org/I4405285715","https://openalex.org/I90344618"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Judith L. Green","raw_affiliation_strings":["Division of Parasitology, MRC National Institute for Medical Research, The Ridgeway, Mill, Hill, London NW7 1AA, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Parasitology, MRC National Institute for Medical Research, The Ridgeway, Mill, Hill, London NW7 1AA, UK","institution_ids":["https://openalex.org/I4405285715"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5076699881","display_name":"Anthony A. Holder","orcid":"https://orcid.org/0000-0002-8490-6058","observed_orcids":["https://orcid.org/0000-0002-8490-6058"]},"institutions":[{"id":"https://openalex.org/I4405285715","display_name":"National Institute for Medical Research","ror":"https://ror.org/00146rb91","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801081054","https://openalex.org/I4210087105","https://openalex.org/I4405285715","https://openalex.org/I90344618"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Anthony A. Holder","raw_affiliation_strings":["Division of Parasitology, MRC National Institute for Medical Research, The Ridgeway, Mill, Hill, London NW7 1AA, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Parasitology, MRC National Institute for Medical Research, The Ridgeway, Mill, Hill, London NW7 1AA, UK","institution_ids":["https://openalex.org/I4405285715"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5001403675"],"corresponding_institution_ids":["https://openalex.org/I109541847"],"apc_list":{"value":3880,"currency":"USD","value_usd":3880},"apc_paid":{"value":3880,"currency":"USD","value_usd":3880},"fwci":3.9107,"has_fulltext":false,"cited_by_count":39,"citation_normalized_percentile":{"value":0.92848365,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"23","issue":"21","first_page":"6019","last_page":"6024"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10091","display_name":"Malaria Research and Control","score":0.9336000084877014,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10091","display_name":"Malaria Research and Control","score":0.9336000084877014,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.03189999982714653,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":0.011800000444054604,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/imidazopyridazines","display_name":"imidazopyridazines","score":0.9909999966621399},{"id":"https://openalex.org/keywords/plasmodium-falciparum","display_name":"Plasmodium falciparum","score":0.9039999842643738},{"id":"https://openalex.org/keywords/calcium-dependent-protein-kinase-1","display_name":"CDPK1","score":0.9020000100135803},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.7689999938011169},{"id":"https://openalex.org/keywords/adme-properties","display_name":"ADME properties","score":0.7850000262260437},{"id":"https://openalex.org/keywords/logd","display_name":"logD","score":0.5989999771118164},{"id":"https://openalex.org/keywords/antimalarial-drug-candidates","display_name":"antimalarial drug candidates","score":0.6840000152587891},{"id":"https://openalex.org/keywords/kinase-inhibitor-selectivity","display_name":"kinase selectivity","score":0.9070000052452087}],"concepts":[{"id":"https://openalex.org/C69366308","wikidata":"https://www.wikidata.org/wiki/Q2272286","display_name":"ADME","level":3,"score":0.9523184299468994},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.8521353006362915},{"id":"https://openalex.org/C2778371730","wikidata":"https://www.wikidata.org/wiki/Q311383","display_name":"Plasmodium falciparum","level":3,"score":0.8499664068222046},{"id":"https://openalex.org/C2777682936","wikidata":"https://www.wikidata.org/wiki/Q408908","display_name":"Pyrazole","level":2,"score":0.7574863433837891},{"id":"https://openalex.org/C2780557392","wikidata":"https://www.wikidata.org/wiki/Q523796","display_name":"Linker","level":2,"score":0.6034882664680481},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.5202075839042664},{"id":"https://openalex.org/C97029542","wikidata":"https://www.wikidata.org/wiki/Q281417","display_name":"Protein kinase A","level":3,"score":0.5112621784210205},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.48319923877716064},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.48010897636413574},{"id":"https://openalex.org/C204171352","wikidata":"https://www.wikidata.org/wiki/Q6545861","display_name":"Ligand efficiency","level":4,"score":0.45813679695129395},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.45494958758354187},{"id":"https://openalex.org/C118792377","wikidata":"https://www.wikidata.org/wiki/Q108584245","display_name":"Selectivity","level":3,"score":0.41410452127456665},{"id":"https://openalex.org/C178910836","wikidata":"https://www.wikidata.org/wiki/Q2196961","display_name":"Molecular model","level":2,"score":0.4105633497238159},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.3876432478427887},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3818230926990509},{"id":"https://openalex.org/C116569031","wikidata":"https://www.wikidata.org/wiki/Q899107","display_name":"Ligand (biochemistry)","level":3,"score":0.25902295112609863},{"id":"https://openalex.org/C2778048844","wikidata":"https://www.wikidata.org/wiki/Q12156","display_name":"Malaria","level":2,"score":0.16965654492378235},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.12069138884544373},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.07395443320274353},{"id":"https://openalex.org/C161790260","wikidata":"https://www.wikidata.org/wiki/Q82264","display_name":"Catalysis","level":2,"score":0.0},{"id":"https://openalex.org/C111919701","wikidata":"https://www.wikidata.org/wiki/Q9135","display_name":"Operating system","level":1,"score":0.0},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.0},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000962","descriptor_name":"Antimalarials","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000962","descriptor_name":"Antimalarials","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010963","descriptor_name":"Plasmodium falciparum","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D010963","descriptor_name":"Plasmodium falciparum","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":true},{"descriptor_ui":"D011494","descriptor_name":"Protein Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011724","descriptor_name":"Pyridazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011724","descriptor_name":"Pyridazines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D015800","descriptor_name":"Protozoan Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D015800","descriptor_name":"Protozoan Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016778","descriptor_name":"Malaria, Falciparum","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D016778","descriptor_name":"Malaria, Falciparum","qualifier_ui":"Q000469","qualifier_name":"parasitology","is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1016/j.bmcl.2013.08.010","doi":"https://doi.org/10.1016/j.bmcl.2013.08.010","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.bmcl.2013.08.010","pdf_url":null,"source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & Medicinal Chemistry Letters","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2804006","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/articles/PMC3809513","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3809513","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3809513","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorg Med Chem Lett","raw_type":"Text"},{"id":"pmid:24035097","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24035097","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & medicinal chemistry letters","raw_type":"Journal Article"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/27af2ada-823e-4476-b54d-545cc115482d","doi":null,"is_oa":true,"landing_page_url":"https://research.birmingham.ac.uk/en/publications/27af2ada-823e-4476-b54d-545cc115482d","pdf_url":null,"source":{"id":"https://openalex.org/S4306402634","display_name":"University of Birmingham Research Portal (University of Birmingham)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I79619799","host_organization_name":"University of Birmingham","host_organization_lineage":["https://openalex.org/I79619799"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Large , J M , Osborne , S A , Smiljanic-Hurley , E , Ansell , K H , Jones , H M , Taylor , D L , Clough , B , Green , J L & Holder , A A 2013 , ' Imidazopyridazines as potent inhibitors of Plasmodium falciparum calcium-dependent protein kinase 1 (PfCDPK1) : Preparation and evaluation of pyrazole linked analogues ' , Bioorganic and Medicinal Chemistry Letters , vol. 23 , no. 21 , pp. 6019-6024 . https://doi.org/10.1016/j.bmcl.2013.08.010","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.bmcl.2013.08.010","doi":"https://doi.org/10.1016/j.bmcl.2013.08.010","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.bmcl.2013.08.010","pdf_url":null,"source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & Medicinal Chemistry Letters","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8048999905586243,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1697524021","display_name":"Expansion of MRCTs Drug Discovery Group (DDG)","funder_award_id":"MC_G1000806","funder_id":"https://openalex.org/F4320334626","funder_display_name":"Medical Research Council"}],"funders":[{"id":"https://openalex.org/F4320322413","display_name":"Medicines for Malaria Venture","ror":"https://ror.org/00p9jf779"},{"id":"https://openalex.org/F4320334626","display_name":"Medical Research Council","ror":"https://ror.org/03x94j517"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":17,"referenced_works":["https://openalex.org/W1490630327","https://openalex.org/W1930237957","https://openalex.org/W1984276710","https://openalex.org/W1996802437","https://openalex.org/W2008525757","https://openalex.org/W2016500542","https://openalex.org/W2033043158","https://openalex.org/W2035032966","https://openalex.org/W2053732861","https://openalex.org/W2062458432","https://openalex.org/W2087028046","https://openalex.org/W2092890873","https://openalex.org/W2095554063","https://openalex.org/W2097638555","https://openalex.org/W2106844715","https://openalex.org/W2111254482","https://openalex.org/W4246239285"],"related_works":["https://openalex.org/W2035032966","https://openalex.org/W2000749166","https://openalex.org/W7098950007","https://openalex.org/W2211322663","https://openalex.org/W2901637517","https://openalex.org/W2620348215","https://openalex.org/W2969059477","https://openalex.org/W6903165927","https://openalex.org/W4295900525","https://openalex.org/W3213452177"],"abstract_inverted_index":{"The":[0,25],"structural":[1],"diversity":[2],"and":[3,23,40,67,77],"SAR":[4,56],"in":[5,64],"a":[6,47,52,73,89],"series":[7],"of":[8,11,35,46,80,96],"imidazopyridazine":[9],"inhibitors":[10],"Plasmodium":[12],"falciparum":[13],"calcium":[14],"dependent":[15],"protein":[16],"kinase":[17,75],"1":[18],"(PfCDPK1)":[19],"has":[20,58],"been":[21],"explored":[22],"extended.":[24],"opportunity":[26],"to":[27,93],"further":[28,94],"improve":[29],"key":[30,60],"ADME":[31,68],"parameters":[32],"by":[33,44],"means":[34],"lowering":[36],"logD":[37],"was":[38,42],"identified,":[39],"this":[41],"achieved":[43],"replacement":[45],"six-membered":[48],"(hetero)aromatic":[49],"linker":[50],"with":[51,62],"pyrazole.":[53],"A":[54],"short":[55],"study":[57],"delivered":[59],"examples":[61],"useful":[63],"vitro":[65],"activity":[66],"profiles,":[69],"good":[70],"selectivity":[71],"against":[72],"human":[74],"panel":[76],"improved":[78],"levels":[79],"lipophilic":[81],"ligand":[82],"efficiency.":[83],"These":[84],"new":[85],"analogues":[86],"thus":[87],"provide":[88],"credible":[90],"additional":[91],"route":[92],"development":[95],"the":[97],"series.":[98]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}